SYK · Stryker Corp
Price
Snapshot
50 fields · last close| Market Cap | $118.1B |
| P/E | 31.81 |
| Float | 362.5M |
| Beta | 0.79 |
| Volatility | 19.8% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 73 |
| Price | 303.00 |
| Change | −1.62% |
| Prev Close | 307.99 |
| Open | 313.96 |
| Day Low | 306.50 |
| Day High | 319.50 |
| Avg Vol | 2 |
| Avg $ Vol | $671.7M |
| 52W High | 396.86 |
| 52W Low | 281.00 |
| 52W Pos | 19.0% |
| From High | −23.65% |
| From Low | +7.83% |
| Max DD 1Y | −28.34% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | −8.50% |
| SMA 50 | −7.95% |
| SMA 200 | −10.55% |
| RSI (14) | 36.4 |
| Vol 30D | 36.8% |
| Vol 90D | 37.6% |
| 1Y Range | 281–397 |
| Daily bars | 506 |
| Perf Week | −4.39% |
| Perf Month | −8.62% |
| Perf Quarter | +2.25% |
| Perf Half Y | −16.87% |
| Perf Year | −20.74% |
| Perf YTD | −12.98% |
| Prev Day | −1.62% |
| Clavix | B |
| Debt / Eq | 0.71 |
| Curr Ratio | 1.89 |
| Int Cover | 6.1× |
| FCF Margin | 17.7% |
| Rev Growth | +9.4% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 27 / 47 |
What SYK does
Stryker Corporation operates as a medical technology company in the United States and internationally.
It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.
The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications.
The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries.
Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Clavix risk grade
regraded every trading daySYK grades B, 73 of 100. Steadiest on Macro Resilience (65), most exposed on Sector Resilience (55, mixed). 0 of the 4 weighted dimensions sit above the Health Care median. Ranks 27 of 47 in Health Care by Clavix score.
How rough the ride is
| SYK | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.79 | 0.81 |
| Volatilityannualized | 19.8% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −28.3% | — |
| Typical daily movemedian absolute daily change | 1.01% | — |
| Days beyond ±3%of the last 252 sessions | 218% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| SYK | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.79 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| SYK | |
|---|---|
| 1 week | −4.4% |
| 1 month | −8.6% |
| Year to date | −13.0% |
| 1 year | −20.7% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| SYK | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 31 Jul |
| Average score0 most bearish, 100 most bullish | 58 |
| Bullish · bearisharticles above 60 · below 40 | 16 · 9 |
| Directionarticles whose tone is improving vs worsening | 16 ↑ 9 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| SYK | |
|---|---|
| Revenue growthyear over year | +9.4% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | SYK | Sector spread | Median |
|---|---|---|---|
| Beta | 0.79 | 0.81 | |
| Volatility | 19.8% | 20.4% | |
| P/E | 31.81 | 26.14 | |
| Debt / equity | 0.71 | 0.71 | |
| Current ratio | 1.89 | 1.58 | |
| FCF margin | 17.7% | 8.6% | |
| Interest coverage | 6.1× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openThe article compares Stryker and Intuitive Surgical, noting both just posted their fifth straight earnings beat with Wall Street cheering for both. It argues a structural difference in their business models separates a compounder (ISRG) from a cyclical recovery story (SYK).
Stryker launched SportSuite Vision, an app cleared by the FDA for use with Apple Vision Pro during hip arthroscopy (a type of minimally invasive hip joint surgery). The product extends Stryker's Sports Medicine lineup and its push into digital surgery tools.
Stryker (SYK) announced it will acquire ZuriMED, bringing in the FiberLocker System to add to its shoulder product line and improve its rotator cuff repair offerings.
Stryker received FDA authorization for SportSuite Vision, a surgical app for Apple Vision Pro (a headset that overlays digital screens onto the surgeon's view of the real world), and surgeons used it to complete the first hip arthroscopy, a minimally invasive hip joint surgery, at a leading academic medical center.
Stryker announced on Aug. 31, 2026 that it has signed a definitive agreement to acquire ZuriMED, a private company whose FiberLocker® System is a already-sold technology designed to strengthen rotator cuff repairs and reduce a common cause of repair failure.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| MDT | Medtronic PLC | A- | $119.2B | 22.55 | 0.60 | Compare |
| CVS | CVS Health Corp | A- | $124.3B | 25.30 | 0.57 | Compare |
| MCK | McKesson Corp | B+ | $107.4B | 23.40 | 0.30 | Compare |
| ISRG | Intuitive Surgical Inc | B- | $130.7B | 41.86 | 1.48 | Compare |
| ELV | Elevance Health Inc | B+ | $89.95B | 17.69 | 0.65 | Compare |
| HCA | HCA Healthcare Inc | B+ | $88.59B | 13.06 | 1.14 | Compare |
| CI | Cigna Group | B+ | $75.64B | 11.64 | 0.27 | Compare |
| ABT | Abbott Laboratories | B+ | $188.2B | 34.68 | 0.54 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.